INVEST.PARTNER.GROW K H A L E E J T I M E S | T H U R S DAY, O C TO B E R 6, 2022
The UAE is on its way towards the successful transformation of the country’s industrial sector into a global manufacturing hub, helped by the country’s strategy to further strengthen its industrial sector and boost economic resilience
Win-Win Situation
Muhammad Ali Bandial ali@khaleejtimes.com
T
he ‘Make it in the Emirates’ campaign is an open invitation to investors, innovators and developers to contribute to the UAE’s industry and advanced technology strategy, ‘Operation 300Bn’. The campaign provides them with an opportunity to benefit from the UAE economy’s tremendous and unique value proposition by investing in future industries and advanced manufacturing and exporting UAE products to new global markets. Operation 300Bn aims to develop the UAE’s industrial sector and enhance its role in stimulating the national economy. It aims to raise the industrial sector’s contribution to the GDP from Dh133 billion to Dh300 billion by 2031. The strategy is aligned with national goals and international commitments relating to advancing sustainable economic growth, deploying clean energy solutions, driving industrial innovation and promoting responsible consumption and production. It is the largest and most comprehensive plan for developing the UAE’s industrial sector and enhancing its role in stimulating the national economy. Over the past few years, the UAE’s industrial sector has grown rapidly despite global economic slowdown and pandemic-driven headwinds. To elaborate this point, in 2021, 220 new factories went into service and began production as the government rolled out measures to improve the ease of doing business and ensuring the industrial sector’s access to financing. The strong performance comes on the back of the UAE’s drive towards making it the go-to investment destination and to fast track its position as a global hub for manufacturing and industry. It offers a solid foundation for business development, with access to major entities’ supply chains, a competent and well-educated workforce, a stable regulatory framework and state-of-theart infrastructure, in an environment conducive to good business. There is a plethora of reasons to look towards the UAE. The country’s industrial ecosystem is conducive to growth, allowing industrialists to easily access financial, advisory and technical support to establish and develop their businesses. Boasting a diverse energy mix at competitive prices, the UAE continues to top regional and global indices in logistics, transport and communications. It has advanced infrastructure, comprising 10 civilian airports, 105 cargo companies, as well as 12 sea and commercial trading ports capable of handling more than 17 million tons and a cargo capacity of 80 million tons annually. The UAE also ranks high in global indicators that measure economic performance and ease of doing business, in addition to enjoying a strong credit rating. The country’s legislative framework is considered the most advanced in the region and its strategic location makes it a global link. The UAE, a melting pot of more than 200 nationalities, enjoys highly-skilled human resources, energy resources, raw materials, a strategic geographic location, advanced infrastructure, transparent laws, reliability and credibility, competitive financing, an ideal quality of life in a diverse, tolerant and secure society, strategic economic partnership agreements and cooperation and trade agreements with various countries around the world. All of these highly sought-after qualities have enabled the UAE to develop its national industry, attract investments, build partnerships, and enter new markets. Building on these, the Make it in the Emirates campaign is geared towards establishing 13,500 industrial companies over the next 10 years in addition to increasing spending on research and development across the industrial sector. The Ministry of Industry and Advanced Technologies (MoIAT), in partnership with Emirates Development Bank (EDB), offers industrial investors, innovators and entrepreneurs to receive significant financial and advisory support from EDB. The bank is the financial driver of Operation 300Bn and provides a wide variety of services to industrial players. Services include financing advanced technology and equipment, sponsoring machinery and equipment upgrades, especially those involving Fourth Industrial Revolution (4.0) applications, as well as green finance, business expansion, structured financing and capital investment, fea-
sibility studies and business incubators. The strategy aims to develop the UAE’s industrial sector, increase its incountry value (ICV), establish the UAE as a global hub for future industries, build the reputation of the UAE’s industrial products through the promotion of exports to global markets and create quality job opportunities in the industrial sector. Furthermore, there is an effort through the campaign to increase the efficiency and sustainability of the production cycles and supply chains by driving research and development (R&D), establishing a comprehensive
system of specifications and standards to create an integrated quality infrastructure for the industrial sector, as well as implementing sustainable industrial policies that reduce resource consumption, and support climate action and carbon neutrality efforts. The main objectives of the strategy aim to create a relevant and attractive business environment for local and international investors in the industrial sector, support the growth of national industries and enhance their global competitiveness, stimulate innovation by accelerating advanced technology
UAE’S TOP REGIONAL AND GLOBAL INDICES IN TRANSPORT, LOGISTICS AND COMMUNICATION
10 105 12 80
civilian airports
cargo companies
sea and commercial trading posts million tons annual cargo capacity
13,500
industrial companies to be established over the next 10 years
adoption across the industrial value chain to upgrade systems and solutions, boost productivity and forge competitive advantages in new areas, build on the solid industrial foundations that have helped fortify the UAE’s position as a global leader in industries of the future, cultivate a culture of innovation in the ministry, and provide a comprehensive array of administrative services in accordance with the highest standards of quality, efficiency and transparency. In order to turn these objectives into fruition, the Ministry is focusing on 11 vital industrial sectors. Under the heading of stimulating growth,
LEVERAGING THE UAE’S COMPETITIVE ADVANTAGES ■ A leadership that supports the industrial sector’s development, looks to the future with a positive outlook, provides and focuses on ensuring stability and a flexible and encouraging environment that achieves the best results ■ Ongoing efforts to enhance ease of doing business and reduce costs ■ Reliable and credible laws and policies that protects investors ■ A commitment to environmental protection and sustainability ■ Financing opportunities, technical support, business incubator ■ Strategic geographic location, export capabilities and comprehensive strategic partnerships ■ Business environment that supports investors and entrepreneurs ■ Reliable access to raw materials as well as traditional and renewable energy ■ Advanced regulatory framework that attracts foreign investments ■ Highly qualified and skilled workforce ■ World-class integrated transportation and logistics infrastructure ■ Excellent quality of life in a diverse, tolerant and safe society ■ World-class communication and information technology infrastructure
the sectors include food, beverage and agricultural technology, pharmaceuticals, electrical equipment and electronics. Within advanced manufacturing, it includes increasing productivity, boosting economic contribution and creating job opportunities, petrochemicals and chemical products, rubber and plastics and machinery and equipment. Finally, the sectors for creating a conducive environment for developing industries of the future include hydrogen, medical technology and space technology. — ali@khaleejtimes.com
II
KHALEEJ TIMES
MAKE IT IN THE EMIRATES
THURSDAY, OCTOBER 6, 2022
Flexible Financial Solutions Offering its customers a variety of options the institution is committed to fostering a sustainable and self-reliant economy in the UAE
T
he UAE is a pioneering, tolerant and forwardthinking nation that has grown into a regional hub for innovation, marked by economic resilience and a favourable business environment. As the UAE’s development bank and a key financial engine for the nation’s economic development and industrial advancement, Emirates Development Bank (EDB) has made it its mission to foster a healthy, sustainable, and self-reliant economy through the provision of financing solutions to SMEs and corporates domiciled in the UAE
Ahmed Mohamed Al Naqbi CEO Emirates Development Bank
and engaged in any of EDB’s five strategic priority sectors. These sectors include advanced technology, food security, healthcare, infrastructure, and manufacturing. Ahmed Mohamed Al Naqbi, CEO of EDB, said: “At EDB, we aim to fill the critical lending gaps faced by the entrepreneurs and businesses who are supporting the
UAE’s economic diversification.” EDB recently announced its partnership with Beehive, adding a new lending feature that allows SMEs to apply for loans of up to Dh5 million directly through its Digital Bank App and receive approval or feedback within five days. The lending service will be available for UAE-based SMEs operating in one of EDB’s five priority sectors and is available on various tenors of up to 60 months. Moreover, it can be availed through EDB’s Digital Banking App, powered by leading UAE-based fintech YAP and enabling SMEs and startups to kick-start their businesses, by providing a business bank account and an IBAN number within 48 hours and then offering a comprehensive range of fast, secure, and round-the-clock banking services. In H1 2022, EDB has approved Dh2.4 billion in financing to empower the UAE industrial sector.
Supporting Domestic Growth The company continues to raise the bar in local manufacturing and industrial innovation
T Clear Vision, Unbreakable Trust
+971 2 599 4000 info@efgme.com PO Box: 8869353
+971 2 550 2682 www.efgme.com MR2 ICAD-2 Musaffah, Abu Dhabi, UAE
he UAE government envisions the industrial sector playing an increasingly vital role in the country’s economic transformation. ‘Operation 300bn’ aims to raise the industrial sector’s contribution to the GDP from Dh133 to Dh300 billion by 2031. Part of this vision is to support the growth of national industries and enhance their global competitiveness. As one of the largest manufacturing businesses in the UAE and a strong supporter of the ‘Make it in the Emirates’ initiative, Ducab has supplied cable solutions to flagship projects in the UAE and beyond. Local customers include the Burj Khalifa, Dubai Metro, Emirates Palace, Burj Al Arab, Expo2020 Dubai, Dubai
Go Local, Build A Brand In The UAE Emirates Float Glass, a subsidiary of Dubai Investments sees the UAE and GCC growing phenomenally well in coming years, which will aid the growth of manufacturing sector
Saleem Raza
General Manager Emirates Float Glass Suneeti Ahuja-Kohli
T
he UAE offers an excellent platform to manufacturers, said Saleem Raza, General Manager, Emirates Float Glass, adding that he supports the campaign ‘Make it in the Emirates’ and is optimistic about the transformation of the UAE’s industrial sector into a manufacturing hub. “This is a growing economy with huge potential. The population is increasing and so is the demand in the local economy, which is a good sign for local manufacturing firms. Second, the strong GCC Union offers a ready market for manufacturers in the UAE to sell their goods at preferential tariffs. The collective economy has depth comparable to some of the big economies of the world. Also, the geographical location of the UAE, combined with excellent business friendly
environment and regulations in the UAE makes a good case for any manufacturer to reach out to the wider world.” The GCC collectively has a population of more than 54 million, and a total GDP of over $3.46 trillion. In perspective, only the US, Japan, China, and Germany have economies larger than $3.8 trillion. Emirates Float Glass is an integrated float glass facility in Abu Dhabi, which has thrived on the back of rising demand in the UAE and the GCC. Established in 2009, during the great recession, EFG is currently utilising 100 per cent capacity and produces 600 tons of glass per day. It produces varieties of clear glass, tinted glass, and pyrolytic glass, which are used across industries such as automobiles, construction, solar panels, health, etc. The firm exports 30 per cent of its products to over 65 countries, and a lion’s share of its produce is sold locally in the UAE and the GCC. “We are happy with the initiative the government has taken (Make it in the Emirates) and we want to align our business goals with this programme, so we can source our requirements locally. The biggest challenge for any company or industry is the supply of raw materials. With this initiative, the government is identifying the needs and encouraging companies to set up bases in the UAE to become a part of the growing ecosystem of manufacturers,” says Raza. Manufacturers like EFG, for now, have to rely on imported raw materials to keep their machines chugging. Sand, which is the biggest component in the manufacturing of glass, is sourced from Saudi Arabia. The other key ingredient, soda ash, is imported from other countries, and the rest five per cent of the raw material is procured from Ras Al Khaimah. “In our case, there is a need for a soda ash producer in the UAE. Soda ash is used in manufacturing glass and it is also a vital raw material for the chemical industry, detergents, paints, and lithium batteries. A lot of oil companies also use
soda ash. This is a good business opportunity,” noted Raza. Emirates Float Glass exports to 65 countries across Asia, Europe, Australia, and South America. “We have been able to make a mark on the global scale because of the logistical support and infrastructure built by the UAE government. Imagine, if there were no competitive ports, it would be very difficult for companies to export. The laws and regulations here are business friendly. The clearance time at the port is less than 12 hours, which is very competitive.” Sitting at his office at the sprawling 320,000 square metre manufacturing facility, Raza said he is confident of improving market conditions and economic prospects. The Abu Dhabi-based firm is looking to add another float line to more than double its current capacity of 600 tons per day. “Recession is an economic cycle that occurs after every decade and a half or more. You cannot control that aspect. But what you can do is prepare and be ready for opportunities that lead to growth. We have faith in the leadership of this country and we know, at the policy front, they will be able to steer the local economy well no, matter the business climate in the West. We started our business during recession, and have grown tremendously in the last decade and a half. We have thrived in all weather conditions and kept adding value and products to the market. We were the first one in the region to introduce pyrolytic coating. And we were the only company in the Middle East that supplies to 65 countries in the world. We expect the collective GCC economy to grow phenomenally in the coming years and aid the growth of all stakeholders in the economy, including the manufacturers,” he concluded.
Airport, Atlantis The Palm, and Yas Marina Circuit. Internationally, Ducab products are today exported to 45 markets across the Gulf, Asia, Oceania, Africa, Europe, and the Americas. Exports cover approximately 60 per cent of overall production, a proportion that has expanded significantly in the last few years. The biggest markets outside the GCC are Hong Kong and India, while the Maldives has emerged as a new and growing market for Ducab. The renewable energy sector represents one of the most exciting new opportunities for Ducab’s
cable solutions. The company’s line of SolarBICC cables cater specifically to the solar energy sector and was selected for two of the region’s largest solar power generation projects, including the Mohammed Bin Rashid Al Maktoum Solar Park in Dubai and Shams 1 in Abu Dhabi. Ducab scores 93.7 per cent on ICV and we support in-country value (ICV) efforts in the manufacturing sector to promote collaboration amongst local industry players and facilitate local goods and services procurement. Ducab works with leading partners across the UAE industrial value chain, such as EGA, KIZAD, and Borouge, while acquiring many of our requirements from UAE-based organisations. Apart from the direct injection of money into UAE’s economy that would otherwise go into imports, such efforts also support local job creation and local talent-hiring and training as the foundation for more sustainable development.
MAKE IT IN THE EMIRATES
THURSDAY, OCTOBER 6, 2022
KHALEEJ TIMES
III
A Track Record of Growth Basem Al Barahmeh General Manager Globalpharma, talks about how the UAE has become a regional hub for the pharmaceutical industry over the past decade and created an environment conducive to sustainable growth Take us through the origin of Globalpharma and its journey from the start to the present in the MENA region. Globalpharma is a wholly owned subsidiary of Dubai Investments. Established in 1998, Globalpharma is currently a market leader in key generic pharma segments with a strong regional footprint. The company started its operations in the UAE in 2003 and expanded its growth in 2008 with product line extensions and new product launches across 14 countries in the GCC and select African markets. Currently, Globalpharma has three manufacturing plants — a state-of-theart Beta-Lactam Penicillin manufacturing plant providing the Amoxicillin and AmoxiClav brands in the larger MENA region, a general medicine manufacturing plant catering to the lifestyle disease segments with a variety of liquid and oral solid dose capabilities and recently, the company launched the first herbal medicine manufacturing site in the Middle East. Glomox (amoxicillin) was the first brand that Globalpharma introduced, followed by Emidol (paracetamol) in 2003, our flagship brand Gloclav (amoxicillin clavulanate) was launched in 2005, and the beginning of our export business. Globalpharma launched the cardiovascular portfolio in 2008, followed by the introduction of our mega brand Atorlip (Atorvastatin) in 2011. The improvement process continued through last year with the herbal medicine manufacturing site in the Middle East and the introduction of our brand MG21. The company’s manufacturing facilities are cGMP (current Good Manufacturing Practice) certified, and have been approved by all health authorities in the Middle East (GCC, UAE, Saudi FDA), Levant, Africa and the CIS regions. Globalpharma manufactures and distributes generic pharmaceutical products in almost all lifestyle disease segments, including cardiovasculars, anti-ulcerants, anti-diabetics, anti-arthritis, analgesics including NSAIDs (non-steroidal anti-inflammatory drugs), respiratory, anti-histamine formulations, anti-infectives and mulitvitamin supplements. The company constantly focusses on continuously expanding its portfolio of covered therapeutic areas, launching new products to meet the ‘un-met needs’ of the patient. During 2022, Globalpharma achieved a great leap in key markets, where in the UAE, our sales showed 67 per cent growth over the previous year and 23 per cent growth in the Saudi Arabia market. Expanding its presence in the Saudi Arabian market, Globalpharma granted access to WASFATY — electronic systems to facilitate medication dispensing — in the Saudi market, allowing higher number of patients to gain access to high quality medicine with affordable prices. What is the state of the pharmaceutical industry in the region and how do you foresee it evolving in the coming years? The Middle Eastern countries, especially those in the GCC, are taking active measures to help the development of the pharmaceutical sector. According to some industry reports, the pharmaceutical market in the Middle East
Basem Al Barahmeh
conducive to sustainable growth. Saudi Arabia is also another strategic market in the region with the pharmaceutical industry being one of the key components of their vision 2030. The Kingdom believes that the pharmaceutical sector is worth developing due to high local demand as well as their proximity to countries in MENA, where free trade agreements are in place. Overall, the global pharmaceutical industry is also increasingly realising the value of a more agile and resilient supply chain model, which facilitates rapid response to changing market forces. Overall, the generic medicine industry boosts competitiveness as generic pharmaceuticals can enhance competition in the drug market by offering more choice and by lowering drug prices to the benefit of health customers. Pharmaceutical industry is encouraged to stay innovative to sustain the momentum and obtain intellectual property rights on their originator drugs.
has witnessed continued growth over the last several years and is projected to grow exponentially in the coming years. The UAE’s pharmaceutical market is expected to grow by 27 per cent between 2021 and 2025, as the country pushes to become a regional pharmaceutical centre with the size of the local pharmaceutical market expected to hit $4.7 billion in value by 2025, up three times from 2011. Favourable economic factors, strong government support for healthcare, the roll-out of mandatory health insurance schemes and with the ambition for excellent healthcare services, the Middle East has huge potential within the pharmaceutical industry. The local and regional companies across the region are quickly gaining pace and the industry is growing because of continued improvement in the health sector, investments by government and implementation of visionary plans. The increasing pressure on governments to cut healthcare budgets could be beneficial for the growth of branded generics manufacturing and this could result in implementation of compulsory healthcare insurance policies to reduce the burden on governments and pass costs onto private hands. The UAE has made impressive inroads to redefine the regional pharmaceutical industry. With a track record of substantial infrastructure investments, unprecedented legal reforms and robust regulations, the UAE has become a regional hub for the pharmaceutical industry over the past decade and created an environment
What role has the company played in supporting the fight against the global pandemic? As a responsible pharmaceutical company, Globalpharma took all efforts to support the government and the community with the best means of treatment and support. The company collaborated all resources and partnered with specialised manufacturers to ensure a seamless production chain and provide timely medical support. Globalpharma worked closely with MOHAP and the different authorities in the UAE to secure the supply of essential medicines and to overcome the impact of global supply constraints. In line with the requirement to support sanitizers during the pandemic, Globalpharma launched the GP+ sanitizer, approved by the Dubai Municipality and manufactured in accordance with the guidelines as outlined by the World Health Organisation (WHO). The formulation offered a quick and persistent action and helped protect against many enveloped and non-enveloped viruses and microorganisms. The surgical disposable facemasks was another product provided by Globalpharma, which was made with high quality melt-blown filter, offering highest filtration rate; and produced under UV sterilisation at the Globalpharma premises that applied the GMP. Globalpharma continues to manufacture and commercialise pharmaceutical products under CGMP (current good manufacturing practice) conditions including antibiotics, cardiovascular,
General Manager, Globalpharma
COMMENTS FROM DISTRIBUTORS Metromed
Metromed’s cooperation with Globalpharma was a turning point in our effort to establish ourselves as one of the top retailers of healthcare services in the UAE. It is terrific to contribute to the accomplishment of such a worthwhile goal as giving patients access to high-quality medication at an affordable price. We began working with Globalphama in 2020 as the sole distributor for the company’s acute portfolio, which includes a variety of flagship brands such as Gloclav™, the top antibiotic from the Amoxicillin Calvulant group and Emifenac DT™. Recently, Metromed was ranked among the top 10 pharmaceutical distributors in the UAE thanks to the fruitful partnership with Globalpharma. Marwan Mubarak Managing Director, Mazrui International Trading Sector (parent company of Metromed)
Alphamed:
Being one of the leading companies in the healthcare sector, we were excited on the alliance with Globalpharma, and being chosen as a distributor for chronic portfolio, including key brands as Atorlip™, Sartan™ ,& EzeAir™, which was in addition to participating in the launch of three brands: Emilok™, Emiros™ and Gloxib™. Alphamed was selected by Globalpharma to launch MG21, the first herbal product inspired by the UAE heritage and proven to be one of the best product launches in the UAE pharmaceutical market. We’re proud of that. Dr Doaa Albarbari CEO, Healthcare and Bin Sina Pharmacies, AKI Group (parent company of Alphamed)
Dr. Mariam Galadari Board Advisor Globalpharma, is a strong advocate for locally manufactured medicines and strongly believes in the strength and performance of the medicines and reiterates their effectiveness just as the foreign medicines, with the raw materials used and imported being from the same source.
Dr. Mariam Galadari
Board Advisor, Globalpharma anti-ulcerants, analgesic, NSAIDs (nonsteroidal anti-inflammatory medicines), food supplements, vitamins, anti-diabetics, respiratory products and anti-histamine formulations. As an organisation that supports Emiratization, can you throw some light on the role of Emirati women within Globalpharma? Globalpharma is proud to have Dr. Mariam Galadari, the first Emirati women pharmacist, who established the Regulatory Department in MOHAP, as the Board Advisor for Globalpharma. Dr. Mariam is setting a great example for Emirati women, inspiring them to pursue their passion and through her dedicated efforts, proved that Emirati women can play an important role in contributing and driving the UAE’s vision. Dr. Maryam has contributed to the preparation of the Pharmacy Law and participated with the team in local tenders and contributed to several committees, such as the evaluation of certificates and practice, the media committee and the inventory committees. During her career, Dr. Mariam received many awards of appreciation. She was honoured in 2016 by the Arab Pharmacists Union in Cairo, becoming the first Arab woman to receive this honour, in appreciation of her role locally and regionally in developing the pharmaceutical sector. She is a strong advocate for locally manufactured medicines and strongly believes in the strength and performance of the medicines and reiterates its effectiveness just as foreign medicines, with the raw materials used and imported remaining from the same source. Tell us about the line of products that are manufactured at Globalpharma. Globalpharma has a state-of-the-art manufacturing site, divided into 3 standalone sites, one for penicillin’s, second for general medicine, and third is the newly launched and the first herbal manufacturing site in Middle East. The company’s flagship brands include Gloclav® (Amoxiclav) tablets and oral suspensions, Glomox® (Amoxicilin) capsule, tablets and oral suspensions, Emifenac® DT (Diclofenac dispersible Tab), Emidol® tablets and Glovit® softgels in the multivitamin range, and all of these are well respected brands across the Middle East and North African markets and trusted by healthcare professionals for their quality and proven efficacy. Please elaborate on the company’s goal of meeting the ‘un-met needs’ of the patient. Globalpharma aims to allow patients access to quality products at affordable
prices. The company provides innovative solutions to improve patient experience and as part of this commitment, Globalpharma has developed ‘Advanced Pack’, the first of its kind in the Middle East, offering patients unique benefits for its comprehensive approach to disease management. The 2D data matrix coding in this ensures comprehensive information on product code, batch number, manufacturing and expiry date to combat medicine counterfeit. This feature also provides QR code access to increase awareness along with a medicine intake chart and a braille calligraphy option to support patients with impaired sight. Likewise, Globalpharma is committed to supporting healthcare professionals in the UAE and the region by strengthening their knowledge and skills as part of its long-term focus on promoting Continuous Medical Education (CME) in the region. Globalpharma is also among the few pharma manufacturers having B-Lactam (penicillin) production site. How beneficial do you think the Make it in the Emirates Forum is for new companies? What do you think is the impact of Forum on promoting and encouraging companies to set up business in the UAE? With the introduction of the Make it in the Emirates national campaign, which is a call to action that supports ‘Operation 300bn’, a national industrial growth strategy, inclusive of the pharmaceutical industry, new markets have been opened for local medicines. This has led to enhancement of the healthcare and the pharmaceutical industry, attracting local and foreign investments within the sector. It has also facilitated the presence of a larger consumer market, opening new markets in the country and being given preferential advantages in foreign markets. As part of the campaign, the government is also placing a lot of emphasis and priority on R&D as part of efforts to promote the adoption of advanced technologies and innovation. This will also help and support the development and the enhancement of the pharmaceutical sector. Tell us something about the future expansion plans of Globalpharma. Globalpharma currently is actively engaged in a couple of projects, including cooperation with multinational companies, to localise manufacturing of their brands in the UAE. The company is also partnering with regional plyers to expand geographically. Our business development teams are also working on projects which will strengthen Globalpharma’s position as a leader through the introduction of unique innovative pharmaceutical forms. Recently, Globalpharma joined the industrial partnership launched between the four countries (UAE, Egypt, Jordan and Bahrain) and is working with companies from these countries on potential partnership projects aimed at developing new medicines and adopting to new technologies and production lines.
IV
KHALEEJ TIMES
THURSDAY, OCTOBER 6, 2022
MAKE IT IN THE EMIRATES
What inspires you, inspires us. Exploring potential
Beyond limitations